T1D Fund
The T1D Fund is a venture philanthropy fund dedicated to accelerating life-changing solutions to treat, prevent, and ultimately cure Type 1 Diabetes (T1D). Established in December 2016, the fund aims to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D. It is the first scaled, mission-driven venture philanthropy fund focused on equity investments in partnership with additional sources of capital, including venture capital, corporations, and foundations. The T1D Fund is strategically aligned with Breakthrough T1D, the leading global T1D research and advocacy organization, to support innovative approaches and novel mechanisms with curative potential.
Industries
Sports
Therapeutics
Venture Capital and Private Equity Principals
Nr. of Employees
small (1-50)